Weight-Loss Drug's Benefits And Risks Revealed in New Study

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.